ANI Pharmaceuticals Inc ANIP:NASDAQ

RT Quote | NASDAQ | USD
Last | 04/20/21 EDT
33.01quote price arrow down-1.02 (-3.00%)
Volume
63,376
52 week range
23.55 - 48.45

...

Loading . . .
  • Open33.96
  • Day High34.91
  • Day Low32.05
  • Prev Close33.01
  • 52 Week High48.45
  • 52 Week High Date04/28/20
  • 52 Week Low23.55
  • 52 Week Low Date11/06/20

Key Stats

  • Market Cap408.33M
  • Shares Out12.37M
  • 10 Day Average Volume0.05M
  • Dividend-
  • Dividend Yield-
  • Beta1.30
  • YTD % Change13.67

KEY STATS

  • Open33.96
  • Day High34.91
  • Day Low32.05
  • Prev Close33.01
  • 52 Week High48.45
  • 52 Week High Date04/28/20
  • 52 Week Low23.55
  • 52 Week Low Date11/06/20
  • Market Cap408.33M
  • Shares Out12.37M
  • 10 Day Average Volume0.05M
  • Dividend-
  • Dividend Yield-
  • Beta1.30
  • YTD % Change13.67

RATIOS/PROFITABILITY

  • EPS (TTM)-1.89
  • P/E (TTM)-17.48
  • Fwd P/E (NTM)9.02
  • EBITDA (MRQ)40.393M
  • ROE (MRQ)-11.04%
  • Revenue (MRQ)208.48M
  • Gross Margin (MRQ)58.19%
  • Net Margin (MRQ)-10.82%
  • Debt To Equity (MRQ)94.88%

EVENTS

  • Earnings Date05/09/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From ANI Pharmaceuticals Inc

There is no recent news for this security.

Latest From Our Partners

Profile

MORE
ANI Pharmaceuticals, Inc. is an integrated specialty pharmaceutical company. The Company is engaged in developing, manufacturing and marketing branded and generic prescription pharmaceuticals. The Company focuses on areas, including controlled substances, anti-cancer (oncolytics), hormones and steroids, and complex formulations. It also performs contract manufacturing for other pharmaceutical companies. Its products include both branded and generic pharmaceuticals. Its...
Patrick Walsh
Chairman
Nikhil Lalwani
President
Stephen Carey
Chief Financial Officer
Address
210 W Main St
Baudette, MN
56623-2467
United States

Top Peers

SYMBOLLASTCHG%CHG
EGRX
Eagle Pharmaceuticals Inc
42.87+0.25+0.59%
BDSI
BioDelivery Sciences International Inc
3.28-0.06-1.80%
OSMT
Osmotica Pharmaceuticals PLC
3.04-0.12-3.80%
ESPR
Esperion Therapeutics Inc
27.54+0.65+2.42%
FLXN
Flexion Therapeutics Inc
8.61-0.15-1.71%